B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 20
- +5 vs. Q4 2025
- Portfolio value
- $134.9M
- −$61.2K (0.0%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ADMAAdma Biologics, Inc. | COM | 3,207,542 | $28.9M | 21.4% | +750,000+30.5% | Added | History |
| PALIPalisade Bio, Inc. | COM | 11,414,285 | $20.0M | 14.8% | +6,914,285+153.7% | Added | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 33,237 | $10.7M | 7.9% | 00.0% | Unchanged | History |
| CLLSCellectis S.A. | SPON ADS | 3,281,501 | $10.4M | 7.7% | 00.0% | Unchanged | History |
| ZLABZai Lab Ltd | ADR | 450,646 | $8.48M | 6.3% | +50,646+12.7% | Added | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,800,556 | $8.05M | 6.0% | 00.0% | Unchanged | History |
| NRXPNRX Pharmaceuticals, Inc. | COM NEW | 3,000,000 | $6.39M | 4.7% | +3,000,000 | New | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 127,500 | $6.15M | 4.6% | +37,500+41.7% | Added | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,500,000 | $5.26M | 3.9% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 100,000 | $5.04M | 3.7% | 00.0% | Unchanged | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 67,500 | $4.93M | 3.7% | +67,500 | New | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 175,706 | $4.88M | 3.6% | 00.0% | Unchanged | History |
| AURAAura Biosciences, Inc. | COM | 597,576 | $4.00M | 3.0% | +25,000+4.4% | Added | History |
| ORKAOruka Therapeutics, Inc. | COM | 75,000 | $3.68M | 2.7% | 00.0% | Unchanged | History |
| SGHTSight Sciences, Inc. | COM | 970,000 | $3.66M | 2.7% | +50,000+5.4% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 135,000 | $2.83M | 2.1% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 7,500 | $631.3K | 0.5% | −12,500−62.5% | Reduced | History |
| FHTXFoghorn Therapeutics Inc. | COM | 102,000 | $487.6K | 0.4% | +102,000 | New | History |
| SLNOSoleno Therapeutics Inc | COM | 7,500 | $251.1K | 0.2% | +7,500 | New | History |
| REPLReplimune Group, Inc. | COM | 26,000 | $198.9K | 0.1% | +26,000 | New | History |